Opus Genetics (IRD US)

Opus Genetics, Inc. is a clinical-stage ophthalmic biopharmaceutical company. The Company focuses on developing and commercializing therapies for the treatment of inherited retinal diseases (IRDs) and other retinal and refractive disorders. Opus Genetics serves customers worldwide.